Communication Dans Un Congrès Année : 2024

Assessing metastatic potential of patients' renal carcinoma on a chip: ONCOTRAP

Claude Cochet
  • Fonction : Auteur

Résumé

Clear cell Renal Cell Carcinoma (ccRCC) is one of the most prevalent kidney cancers, which is often asymptomatic and thus discovered at a metastatic state (mRCC). mRCC are highly heterogeneous tumors composed of subclonal populations that lead to poor treatment response rate. Several recent works explored the potential of ccRCC tumoroids culture derived from patients. Following the observation that ccRCC tumoroids can create their own niche by secreting extracellular matrix components, we developed the first scaffold-free tumoroid model of ccRCC tumors. This model enables to evaluate invasiveness of renal cancer cells in a 3D context toward a metastatic niche. Inserted into a chip named ONCOTRAP, these tumoroids provide also a robust preclinical test to study metastatic process.
Fichier principal
Vignette du fichier
EUROoCS2024_Abstract-Cesana.pdf (463.94 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04891117 , version 1 (16-01-2025)

Identifiants

  • HAL Id : hal-04891117 , version 1

Citer

Odile Filhol, Beatrice Cesana, Irinka Séraudie, Catherine Pillet, Elisa Lambert, et al.. Assessing metastatic potential of patients' renal carcinoma on a chip: ONCOTRAP. EUROoCS conference 2024, EUROoCS, Jul 2024, Milan, Italy. ⟨hal-04891117⟩
0 Consultations
0 Téléchargements

Partager

More